First National Bank of Omaha’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-13,435
Closed -$2.83M 334
2022
Q1
$2.83M Sell
13,435
-784
-6% -$165K 0.14% 160
2021
Q4
$3.41M Sell
14,219
-767
-5% -$184K 0.16% 151
2021
Q3
$4.24M Sell
14,986
-570
-4% -$161K 0.22% 142
2021
Q2
$4.35M Hold
15,556
0.23% 136
2021
Q1
$4.35M Buy
15,556
+307
+2% +$85.9K 0.23% 136
2020
Q4
$3.73M Sell
15,249
-378
-2% -$92.6K 0.2% 142
2020
Q3
$4.43M Sell
15,627
-163
-1% -$46.2K 0.28% 118
2020
Q2
$4.23M Buy
15,790
+42
+0.3% +$11.2K 0.28% 118
2020
Q1
$4.98M Sell
15,748
-13
-0.1% -$4.11K 0.39% 85
2019
Q4
$4.68M Sell
15,761
-584
-4% -$173K 0.28% 122
2019
Q3
$3.81M Sell
16,345
-287
-2% -$66.8K 0.25% 132
2019
Q2
$3.89M Buy
16,632
+45
+0.3% +$10.5K 0.25% 133
2019
Q1
$3.92M Sell
16,587
-213
-1% -$50.4K 0.27% 124
2018
Q4
$5.06M Sell
16,800
-3,677
-18% -$1.11M 0.38% 91
2018
Q3
$7.2M Sell
20,477
-269
-1% -$94.5K 0.4% 83
2018
Q2
$6.17M Buy
20,746
+21
+0.1% +$6.25K 0.36% 89
2018
Q1
$5.87M Sell
20,725
-177
-0.8% -$50.2K 0.35% 92
2017
Q4
$6.72M Sell
20,902
-348
-2% -$112K 0.39% 81
2017
Q3
$6.73M Buy
21,250
+2,545
+14% +$806K 0.41% 76
2017
Q2
$5.28M Sell
18,705
-1,081
-5% -$305K 0.33% 100
2017
Q1
$5.61M Sell
19,786
-1,682
-8% -$477K 0.34% 100
2016
Q4
$6.26M Buy
21,468
+2,624
+14% +$765K 0.39% 83
2016
Q3
$5.9M Sell
18,844
-598
-3% -$187K 0.43% 81
2016
Q2
$4.7M Buy
19,442
+507
+3% +$123K 0.35% 102
2016
Q1
$4.93M Sell
18,935
-640
-3% -$167K 0.37% 95
2015
Q4
$6K Sell
19,575
-274
-1% -$84 0.43% 87
2015
Q3
$5.79K Sell
19,849
-8,995
-31% -$2.63K 0.43% 88
2015
Q2
$10.8K Hold
28,844
0.74% 30
2015
Q1
$10.8K Buy
28,844
+146
+0.5% +$55 0.74% 30
2014
Q4
$9.74M Buy
28,698
+2,347
+9% +$797K 0.68% 31
2014
Q3
$8.72M Sell
26,351
-1,398
-5% -$462K 0.63% 39
2014
Q2
$8.75M Buy
27,749
+2,142
+8% +$675K 0.62% 39
2014
Q1
$7.83M Sell
25,607
-6,181
-19% -$1.89M 0.58% 49
2013
Q4
$8.89M Buy
31,788
+1,888
+6% +$528K 0.68% 35
2013
Q3
$7.2M Buy
29,900
+42
+0.1% +$10.1K 0.62% 44
2013
Q2
$6.43K Buy
+29,858
New +$6.43K 0.55% 54